Antibody Technology
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
6
NCT05074550
Safety Evaluation Study for Patients With Polycythemia Vera
Phase: Phase 1
Role: Lead Sponsor
Start: Aug 24, 2022
Completion: Mar 31, 2024
Loading map...